Esperion Therapeutics
ESPR
#6741
Rank
โ‚ฌ0.46 B
Marketcap
2,36ย โ‚ฌ
Share price
2.49%
Change (1 day)
116.33%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.66 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ0.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.59 B12.15%
2022-12-31โ‚ฌ0.53 B4.33%
2021-12-31โ‚ฌ0.51 B39.82%
2020-12-31โ‚ฌ0.36 B110.44%
2019-12-31โ‚ฌ0.17 B208.74%
2018-12-31โ‚ฌ56.23 M103.58%
2017-12-31โ‚ฌ27.62 M74.92%
2016-12-31โ‚ฌ15.79 M107.71%
2015-12-31โ‚ฌ7.6 M-4.89%
2014-12-31โ‚ฌ7.99 M162.65%
2013-12-31โ‚ฌ3.04 M-83.7%
2012-12-31โ‚ฌ18.67 M194.44%
2011-12-31โ‚ฌ6.34 M
2002-12-31โ‚ฌ12.11 M-9.65%
2001-12-31โ‚ฌ13.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ1.13 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.37 B 106.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ121.15 B 18,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.74 B 1,065.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.58 B-12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.12 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA